Vendor Intelligence Report: HealthTide Biotech

Published 3 Jul 2026. 23-page investigative report on who is behind HealthTide Biotech: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 3 pages are free to read on this page.

Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.

Executive summary

Across 15 Finnrick lab tests, HealthTide Biotech records 11 passes and 4 failures, a 73% overall pass rate. The signal is mixed rather than uniformly bad: GHK-Cu is the strongest current product signal, Retatrutide is more defensible on lab performance but carries separate GLP-1 import risk for US buyers, and Tirzepatide is the weak point. Ratings also become less comforting under stricter Finnrick grading for dose-sensitive buyers.

The identity file is less settled than the product record. HealthTide’s archived pages support a real multilingual storefront, but founding, copyright, ICP, address, and company-name details do not resolve into a clean verified manufacturer profile. The Qingdao address appears in a tax-authority notice as a business-secretary managed location, not evidence of a lab, warehouse, or QC site.

The strongest upstream anchor is a CONTIDE Biotech ChemicalBook profile tying a Hong Kong-linked entity, a named legal representative, and HealthTide sales-email infrastructure. That same profile now returns 404, while health-tide.com was parked during the July 2026 field check even as mail and DNS changes suggested reconfiguration rather than abandonment.

Channel risk is now part of the buying decision. HealthTide social profiles remained active, one TikTok bio carried a US WhatsApp number, and a Texas-facing near-name seller showed overlapping catalog and redacted/shared testing language. The archive also reaches into botulinum-toxin, anabolic-steroid, and prescription-adjacent listings, while US GLP-1 API shipments remain exposed to FDA import-alert detention because HealthTide/CONTIDE were not found on the Green List.

Inside the full report:

  • Complete Appendix A product-by-methodology Finnrick lab data for all three tested products
  • Archived HealthTide storefront captures, including Tirzepatide and botulinum-toxin pages
  • CONTIDE ChemicalBook archive-to-404 comparison and HealthTide API email-domain linkage
  • DNS, WHOIS, Google Workspace, Alibaba Cloud, and mail-routing analysis
  • AKA Healthtides reseller assessment, Trustpilot footprint, and COA/redaction review
  • FDA Import Alert 66-80 Green List review for GLP-1 API shipments

Risk assessment

  • Supply-chain and identity-opacity risk — high: CONTIDE is the strongest upstream anchor but its ChemicalBook profile now returns 404; primary registry/factory verification was not retrieved, and HealthTide/HealthTide Tech/CONTIDE labels rotate across records.
  • High-risk regulated-product catalog risk — high: Archived records show Botulinum toxin/BOTOX 100IU, Drostanolone Enanthate, Tianeptine, and affiliated Tadalafil listings without verifiable licensing, sterility release, or lot-level COA controls in the reviewed materials.
  • Tirzepatide quality-control risk — medium: Tirzepatide is HealthTide’s weakest tested product: 6 Finnrick tests, 4 pass / 2 fail, current rating 76.68%.
  • US GLP-1 import-detention risk — medium: HealthTide/CONTIDE were not found on FDA Import Alert 66-80 Green List as of the June 22, 2026 field check, affecting US-bound Tirzepatide/Semaglutide GLP-1 API shipments.
  • Brand-confusion and unofficial-reseller risk — medium: AKA Healthtides mirrors the HealthTide catalog and uses redacted/shared testing language; HealthTide provides no official reseller list, official-channels page, or COA verification portal in the reviewed materials.
  • Storefront continuity and channel-verification risk — medium: health-tide.com is parked while DNS/MX infrastructure is being reconfigured, pushing buyers toward social, WhatsApp, B2B, or email contacts without a stable live storefront.